• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国湖北省16个城市严重急性呼吸综合征冠状病毒2(SARS-CoV-2)传播的趋势动态

Trend Dynamics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission in 16 Cities of Hubei Province, China.

作者信息

Fawad Muhammad, Mubarik Sumaira, Malik Saima Shakil, Hao Yangyang, Yu Chuanhua, Ren Jingli

机构信息

Henan Academy of Big Data, Zhengzhou University, Zhengzhou 450052, People's Republic of China.

School of Mathematics and Statistics, Zhengzhou University, Zhengzhou 450001, People's Republic of China.

出版信息

Clin Epidemiol. 2020 Jul 2;12:699-709. doi: 10.2147/CLEP.S254806. eCollection 2020.

DOI:10.2147/CLEP.S254806
PMID:32669878
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7337437/
Abstract

OBJECTIVE

A severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was detected by researchers from a patient in Wuhan, Hubei province, China, in December 2019, and broke out in January 2020. Then, the pandemic was detected in countries around the world. Therefore, precise estimates of its current and future trends are highly required for future policy implications.

METHODS

We retrieved data from the Health Commission of Hubei, China. Logistic-S curve model was used to estimate the current and future trends of SARS-CoV-2-infected cases among 16 cities of Hubei, China from Jan-11 to Feb-24, 2020.

RESULTS

Out of 64,287 confirmed cases of SARS-CoV-2 infection in Hubei, higher percentage of cases were in Wuhan and Xiaogan. The highest death percentage was found in Wuhan and Qianjiang. A significant percentage of cures were found in Enshi Prefecture and Huanggang, while Wuhan showed the lowest percentage of cures. Rising trends in infected cases were observed throughout the study period, particularly in Wuhan, and a higher trend was observed after 12-Feb. Gradual decline trend of SARS-CoV-2 cases was observed during Feb-25 to Mar-15 in Hubei Province. Future forecast showed that the average number of SARS-CoV-2-infected cases might be decreased or stable in Hubei in the coming 20 days.

CONCLUSION

The public must take precautionary measures in order to control and prevent disease spread and avoid extra travelling.

摘要

目的

2019年12月,中国湖北省武汉市的一名患者被研究人员检测出感染了严重急性呼吸综合征冠状病毒2(SARS-CoV-2),该病毒于2020年1月爆发。随后,全球多个国家都检测到了这种大流行病。因此,对于未来的政策影响而言,迫切需要对其当前和未来趋势进行精确估计。

方法

我们从中国湖北省卫生健康委员会获取了数据。采用逻辑斯蒂S曲线模型来估计2020年1月11日至2月24日期间中国湖北省16个城市中感染SARS-CoV-2病例的当前和未来趋势。

结果

在湖北省64287例确诊的SARS-CoV-2感染病例中,武汉和孝感的病例占比更高。武汉和潜江的死亡率最高。恩施州和黄冈的治愈率较高,而武汉的治愈率最低。在整个研究期间,感染病例呈上升趋势,尤其是在武汉,2月12日之后上升趋势更为明显。2月25日至3月15日期间,湖北省SARS-CoV-2病例呈逐渐下降趋势。未来预测显示,在未来20天内,湖北省SARS-CoV-2感染病例的平均数量可能会减少或保持稳定。

结论

公众必须采取预防措施,以控制和预防疾病传播,避免不必要的出行。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47c2/7337437/be2015040eae/CLEP-12-699-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47c2/7337437/3b106d0432c1/CLEP-12-699-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47c2/7337437/c29daee599a2/CLEP-12-699-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47c2/7337437/93c71ff3e189/CLEP-12-699-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47c2/7337437/3c3af1024228/CLEP-12-699-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47c2/7337437/be2015040eae/CLEP-12-699-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47c2/7337437/3b106d0432c1/CLEP-12-699-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47c2/7337437/c29daee599a2/CLEP-12-699-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47c2/7337437/93c71ff3e189/CLEP-12-699-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47c2/7337437/3c3af1024228/CLEP-12-699-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47c2/7337437/be2015040eae/CLEP-12-699-g0005.jpg

相似文献

1
Trend Dynamics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission in 16 Cities of Hubei Province, China.中国湖北省16个城市严重急性呼吸综合征冠状病毒2(SARS-CoV-2)传播的趋势动态
Clin Epidemiol. 2020 Jul 2;12:699-709. doi: 10.2147/CLEP.S254806. eCollection 2020.
2
The spatial transmission of SARS-CoV-2 in China under the prevention and control measures at the early outbreak.疫情初期防控措施下新型冠状病毒在中国的空间传播。
Arch Public Health. 2021 Jan 13;79(1):8. doi: 10.1186/s13690-021-00529-z.
3
Study on SARS-CoV-2 transmission and the effects of control measures in China.中国 SARS-CoV-2 传播及防控措施效果研究。
PLoS One. 2020 Nov 30;15(11):e0242649. doi: 10.1371/journal.pone.0242649. eCollection 2020.
4
Risk estimation of the SARS-CoV-2 acute respiratory disease outbreak outside China.中国境外新型冠状病毒急性呼吸道疾病爆发的风险评估
Theor Biol Med Model. 2020 Jun 5;17(1):9. doi: 10.1186/s12976-020-00127-6.
5
Spread of Coronavirus 2019 From Wuhan to Rural Villages in the Hubei Province.2019年冠状病毒从武汉向湖北省农村地区的传播。
Open Forum Infect Dis. 2020 Jun 12;7(7):ofaa228. doi: 10.1093/ofid/ofaa228. eCollection 2020 Jul.
6
Children with SARS-CoV-2 infection during an epidemic in China (outside of Hubei province).在中国(湖北省以外)疫情期间感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的儿童。
Ann Transl Med. 2020 Jul;8(14):849. doi: 10.21037/atm-20-2908.
7
Modeling the epidemic dynamics and control of COVID-19 outbreak in China.中国新冠疫情爆发的流行动力学建模与防控
Quant Biol. 2020;8(1):11-19. doi: 10.1007/s40484-020-0199-0. Epub 2020 Mar 11.
8
Ecological Study on Differences in COVID-19 Fatality among Wuhan, Rest of Hubei, and Rest of China.武汉、湖北省其他地区和中国其他地区 COVID-19 病死率差异的生态学研究。
J Epidemiol Glob Health. 2021 Mar;11(1):42-45. doi: 10.2991/jegh.k.200902.001. Epub 2020 Sep 10.
9
Impact of Population Emigration from Wuhan and Medical Support on COVID-19 Infection in China.人口迁出武汉和医疗支援对中国 COVID-19 感染的影响。
J Epidemiol Glob Health. 2021 Jun;11(2):178-185. doi: 10.2991/jegh.k.201121.001. Epub 2020 Dec 8.
10
Trends and prediction in daily incidence of novel coronavirus infection in China, Hubei Province and Wuhan City: an application of Farr's law.中国、湖北省及武汉市新型冠状病毒感染每日发病率的趋势与预测:法尔定律的应用
Am J Transl Res. 2020 Apr 15;12(4):1355-1361. eCollection 2020.

引用本文的文献

1
Effect of Knowledge/Practice of COVID-19 Prevention Measures on Return-to-Work Concerns; Attitudes About the Efficacy of Traditional Chinese Medicine: Survey on Supermarket Staff in Huanggang, China.新冠病毒肺炎预防措施的知识/实践对复工担忧的影响;对中医药疗效的态度:中国黄冈超市员工调查。
Front Public Health. 2021 Sep 16;9:722604. doi: 10.3389/fpubh.2021.722604. eCollection 2021.
2
A Framework for a Statistical Characterization of Epidemic Cycles: COVID-19 Case Study.疫情周期统计特征的框架:以新冠疫情为例
JMIRx Med. 2021 Mar 18;2(1):e22617. doi: 10.2196/22617. eCollection 2021 Jan-Mar.
3
Statistical analysis of COVID-19 infection caused by environmental factors: Evidence from Pakistan.

本文引用的文献

1
Prioritization of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics.基于已建立的人体药代动力学得出的血浆和靶部位浓度,对抗 SARS-CoV-2 药物再利用机会进行优先排序。
Clin Pharmacol Ther. 2020 Oct;108(4):775-790. doi: 10.1002/cpt.1909. Epub 2020 Jun 14.
2
Structural elucidation of SARS-CoV-2 vital proteins: Computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and Nsp13 helicase.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)关键蛋白的结构解析:计算方法揭示了针对主要蛋白酶、Nsp12聚合酶和Nsp13解旋酶的潜在候选药物。
J Pharm Anal. 2020 Aug;10(4):320-328. doi: 10.1016/j.jpha.2020.04.008. Epub 2020 Apr 28.
3
基于巴基斯坦数据的环境因素引发的 COVID-19 感染的统计分析。
Life Sci. 2021 Mar 15;269:119093. doi: 10.1016/j.lfs.2021.119093. Epub 2021 Jan 18.
Antiviral treatment of COVID-19.COVID-19 的抗病毒治疗。
Turk J Med Sci. 2020 Apr 21;50(SI-1):611-619. doi: 10.3906/sag-2004-145.
4
Exported Wuhan Novel Coronavirus Infection: An Expected Rate with Reference to Main Destination of Chinese Tourist, Thailand.输入的武汉新型冠状病毒感染病例输出情况:参考中国游客主要目的地泰国的预期感染率
Int J Prev Med. 2020 Feb 21;11:28. doi: 10.4103/ijpvm.IJPVM_39_20. eCollection 2020.
5
Discovering drugs to treat coronavirus disease 2019 (COVID-19).发现治疗2019冠状病毒病(COVID-19)的药物。
Drug Discov Ther. 2020;14(1):58-60. doi: 10.5582/ddt.2020.01012.
6
Therapeutic options for the 2019 novel coronavirus (2019-nCoV).2019新型冠状病毒(2019-nCoV)的治疗选择。
Nat Rev Drug Discov. 2020 Mar;19(3):149-150. doi: 10.1038/d41573-020-00016-0.
7
COVID-19: combining antiviral and anti-inflammatory treatments.2019冠状病毒病:联合抗病毒与抗炎治疗
Lancet Infect Dis. 2020 Apr;20(4):400-402. doi: 10.1016/S1473-3099(20)30132-8. Epub 2020 Feb 27.
8
The psychological impact of quarantine and how to reduce it: rapid review of the evidence.隔离的心理影响及其减轻方法:快速综述证据。
Lancet. 2020 Mar 14;395(10227):912-920. doi: 10.1016/S0140-6736(20)30460-8. Epub 2020 Feb 26.
9
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.中国2019年冠状病毒病(COVID-19)疫情的特征及重要经验教训:来自中国疾病预防控制中心72314例病例报告的总结
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
10
Novel Coronavirus disease 2019 (COVID-19): The importance of recognising possible early ocular manifestation and using protective eyewear.2019年新型冠状病毒病(COVID-19):认识可能的早期眼部表现及使用防护眼镜的重要性。
Br J Ophthalmol. 2020 Mar;104(3):297-298. doi: 10.1136/bjophthalmol-2020-315994.